Few Individuals With Mental, Substance Use Disorders Receive Guideline-Consistent Treatment
By Lori Solomon HealthDay Reporter
FRIDAY, Feb. 14, 2025 -- A small number of individuals with mental and substance use disorders receive guideline-consistent treatment worldwide, according to a study published online Feb. 5 in JAMA Psychiatry.
Daniel V. Vigo, M.D., Dr.P.H., from the University of British Columbia in Vancouver, Canada, and colleagues examined the proportion of mental and substance use disorders receiving guideline-consistent treatment in multiple countries. The analysis included 56,927 respondents from World Mental Health surveys (2001 to 2019).
The researchers found that the proportion of 12-month person-disorders receiving effective treatment was 6.9 percent. Major barriers included low perceived need (46.5 percent), low treatment contact given perceived need (34.1 percent), and low effective treatment given minimally adequate treatment (47.0 percent), with substantial variation across disorders. Country-level general medical treatment resources were more important than mental health treatment resources in predicting guideline-consistent treatment. Significant predictors were largely mediated by treatment contact.
"These results highlight the importance of increasing perceived need, the largest barrier to effective treatment; training primary care clinicians in recognition and treatment of mental disorders; and improving the quality of care, especially from minimally adequate to effective treatment," the authors write.
Several authors disclosed ties to relevant organizations.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted February 2025
Read this next
Helping Others Linked to Higher Level of Cognitive Function
THURSDAY, Aug. 21, 2025 -- Helping others, both via formal volunteering and informal helping, is associated with higher levels of cognitive function and slower cognitive decline...
TAR-200 Monotherapy Promising for BCG-Unresponsive Bladder Cancer
THURSDAY, Aug. 21, 2025 -- For patients with Bacillus Calmette-Guérin (BCG)-unresponsive high-risk non-muscle-invasive bladder cancer (NMIBC), an intravesical...
Work-Related Income Drops for Parents of Children Diagnosed With Type 1 Diabetes
THURSDAY, Aug. 21, 2025 -- Work-related income decreases sharply for mothers and fathers of children diagnosed with type 1 diabetes, with similar effects across sociodemographic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.